AI assistant
ECS BOTANICS HOLDINGS LTD — Capital/Financing Update 2021
Jun 17, 2021
64818_rns_2021-06-17_e5c78601-2ae9-4ad0-93b6-31a156fa3aec.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
ASX ANNOUNCEMENT
ECS Botanics Holdings Ltd (ASX:ECS)
18 June 2021
==> picture [104 x 104] intentionally omitted <==
Release from Escrow
ECS Botanics Holdings Ltd (ASX: ECS) (“ECS” or the “Company”) hereby advises pursuant to Listing Rule 3.10A that the following securities are to be released from escrow on 22 July 2021:
| CLASS | Number |
|---|---|
| Fully paid ordinaryshares | 227,061,430 |
| Performance Rights | 99,093,266 |
| Unquoted Options (exercisable at $0.08 each, expiring11 January2022) | 20,375,000 |
About ECS Botanics Holdings Ltd
ECS Botanics Holdings Ltd is a vertically integrated medicinal cannabis and industrial hemp business. The company owns farms and medicinal cannabis facilities in Tasmania and Victoria for the cultivation, processing, and manufacturing of medicinal cannabis. ECS manufactures to EU GMP standards and also has the necessary licences to cultivate and manufacture medicinal cannabis for the wholesale extract, final dose and premium dry flower market. ECS cultivates hemp for the wholesale market and its retail food and wellness brand, while having obtained all the necessary licences to grow, supply and manufacture. ECS’ core focus is scale and low-cost production, without compromising quality.
For further information, please contact:
Alexander Keach, Managing Director [email protected]
Authorised on behalf of ECS by Alex Keach, Managing Director
==> picture [596 x 69] intentionally omitted <==